Introduction
Due to great advancement in the field of science and technology there is increased life expectancy all over the world. It has also increased the expectations of long sexual life. But medical advancement is not up to the expectations. So the number of hypogonads is increasing day by day. It may be due to sedentary life style with increased obesity, increased tension or stressed lifestyle among all groups of populations.
It may be due to endocrine disruptors like so many chemicals, drugs and environmental pollutants which destruct different endocrine glands like gonads, pituitary, etc. 1 On the other hand hypogonadism is found more in patients with diabetes. 2 It may happen that hypogonadism causes fat deposition which in turn leads to insulin resistance and ultimately leads to diabetes. It is also proved by the fact that testosterone replacement in hypogonadal patients decreases insulin resistance and improves blood sugar control. 3 Visceral obesity is associated with insulin resistance, diabetes mellitus and also with hypogonadism. [4] [5] [6] [7] [8] So treatment of hypogonadism may increase muscle mass, improve glucose uptake and thereby can decrease insulin resistance and can decrease the number of the diabetic patients. 9 There is no clear consensus for an accepted lower limit of normal testosterone level. 10 It is established that patients with testosterone level below 12 nmol/L with signs and symptoms of hypogonadism can be benefited by replacement with testosterone. 10,11 So testosterone level of < 12 nmol / L is taken as cut off point and these subjects are taken as patients with hypogonadism.
Insulin resistance is defined as impaired whole body insulin mediated glucose disposal. Clinically insulin resistance is the inability of a known quantity of exogenous or endogenous insulin to increase glucose uptake and utilization in an individual as much as it does in a normal population. It may be measured by Homeostasis model assessment (HOMA-R) method. In this method if the value is more than 1 (one), it is considered that the patient has got insulin resistance. Insulin resistance may cause metabolic syndrome associated with obesity, hypertension, atherosclerosis and dyslipidaemia. Although a relationship between insulin resistance and fat gain has been demonstrated it is not clear whether insulin resistance is a promoting fa ctor or simply a consequence of fat gain. [12] [13] [14] Now a days patients with hypogonadism and erectile dysfunction are considered more frequent than those which were thought previously. 15 Patients with type 2 diabetes have impaired sexual life which is worsened by hypogonadism. Low testosterone in type 2 diabetes is in fact associated with more severe erectile dysfunction, hypoactive sexual desire and low intercourse frequency. 3 Several studies have shown that testosterone replacement in diabetic patients with hypogonadism or without hypogonadism has improved the erectile dysfunction. 3, 10 Among the multiple causes of erectile dysfunction hypogonadism is an important one which in most of the time is over looked in the common diseases like diabetes mellitus. But the treatment of hypogonadism is satisfactory and promising. 9 So every rational patient should be evaluated for hypogonadism.
Materials and method
This cross sectional study was conducted to evaluate insulin resistance in hypogonad patients. Purposively a total of 161 male subjects of 20 to 60 years without having any systemic illness that can affect testosterone level were selected in this study. Serum testosterone level was measured in all the subjects. Among them 113 subjects who had serum testosterone level of ≤ 12 nmol/L irrespective of blood glucose level were grouped as hypogonads. On the other hand 48 subjects were selected as eugonads having testosterone level of > 12 nmol/L with normal blood glucose level. Hypogonad subjects were further subdivided based on blood glucose level into diabetics and non diabetics. Status of insulin resistance was determined using HOMA-R method as described by Matthews et al. 16 Detailed history and clinical findings were evaluated and documented with special emphasis on erectile status. Informed co nsent was taken from all the study subjects after explaining the purpose of the study in detail. Proportions of the studied variables and ANOVA were done by using software SPSS for windows version 11.5. 
Results
In this study age distribution, erectile status, status of insulin resistance done by HOMA-R and comparison of insulin resistance among the study subjects were evaluated. Regarding age distribution the highest proportion (38.9%) of hypogonadism was in ≥ 50 years age group whereas highest proportion (39.6%) of the eugonads was in the age group of 40 to 49 years (Table I) . 
Discussion
This cross sectional study was carried out to determine the proportion of insulin resistance among male subjects with hypogonadism.
The study revealed that more than two third of hypogonads presented with erectile dysfunction and were in ≥ 50 years of age group. It is striking that a remarkable number of eugonads also had similar complaints and were within 40 to 49 years of age group clearly exploring the fact of vulnerability of aging for erectile dysfunction independent of gonadal status though the major proportion were hypogonads. These findings are almost similar to the study done by Rhoden et al. 17 But Slag et al. 18 showed that erectile dysfunction is a common problem in middle-aged men in their population. This discrepancy might be due to advanced health facilities and awareness leading to early recognition in the western society.
Insulin resistance is the hallmark feature of type 2 diabetes and is also an important component of the metabolic syndrome. There is evidence to suggest that testosterone is an important regulator of insulin sensitivity in men and observational studies have shown that testosterone levels are low in men with diabetes. 6 Visceral obesity is also more among hypogonads which is strongly associated with insulin resistance. 10, 19 These findings are in accordance with our results which shows more than 90% of hypogonads had insulin resistance. Moreover we found a substantial proportion of eugonads to have insulin resistance and erectile dysfunction. Grover et al. 20 showed that erectile dysfunction is independently associated with metabolic syndrome.
Insulin resistance was measured by using HOMA-R among the groups. The average HOMA-R was more in the subjects with hypogonadism with diabetes. Highly significant (p-value <0.001) difference was found among the study subjects (Table IV) . More than half of the hypogonad subjects had weak erectile quality (54.0%) which were followed by absent erectile quality in 32.7%. Rest of the subjects was normal functioning (13.3%). Among the eugonad subjects the percentage of normal erectile quality was 41.7% and weakly present erectile quality was found in 41.6% subjects and 16.7% subjects had no erectile quality (Table II) .
Table II: Erectile status of the study subjects
More than ninety percent of the hypogonad subjects had insulin resistance (91.2%). On the other hand among the eugonad subjects 60.4% had insulin resistance (Table III) . 
